Dr. Diba Kadivar | Inorganic Chemistry | Best Researcher Award

Published on by Chemistry Awards

Dr. Diba Kadivar | Inorganic Chemistry| Best Researcher Award

Dr. Diba Kadivar | Inorganic Chemistry| Ph. D. graduate in inorganic chemistry at chemistry and chemical engineering research center of iran , Iran

Dr. Diba Kadivar is a Ph.D. graduate in Inorganic Chemistry with extensive expertise in anticancer platinum complexes. She has been serving as a technical assistant at the Iranian Food and Drug Administration (IFDA) for over eight years, contributing to pharmaceutical research and regulatory affairs. Dr. Kadivar has conducted significant studies on the synthesis, characterization, and biological activity of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and aliphatic N-substituted glycine derivatives on platinum complexes’ pharmacological properties. She has published multiple papers in reputed journals and actively collaborates on cancer cell line studies. Passionate about innovative drug discovery, she has contributed to the development of metal-based nanocomplexes for potential therapeutic applications. Dr. Kadivar remains committed to advancing medicinal inorganic chemistry through her research and collaborations, aiming to enhance the effectiveness of anticancer therapies while minimizing side effects.

Professional Profile :         

Google Scholar

Orcid

Scopus  

Summary of Suitability for Award:

Dr. Diba Kadivar is a distinguished researcher in inorganic chemistry, specializing in anticancer platinum complexes. With a Ph.D. in inorganic chemistry and eight years of experience as a technical assistant at the Iranian Food and Drug Administration (IFDA), she has made notable contributions to the development of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and the role of aliphatic N-substituted glycine derivatives in enhancing the biological activities of platinum complexes. She has published in reputable journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications, with a citation index of 18. Dr. Diba Kadivar’s innovative research on platinum-based anticancer drugs, scientific contributions, and expertise in inorganic medicinal chemistry make her highly suitable for the “Best Researcher Award.” Her work advances cancer treatment strategies, and her publications demonstrate scientific excellence and impact in medicinal chemistry.

🎓Education:

Dr. Diba Kadivar pursued her doctoral studies in Inorganic Chemistry, specializing in metal-based drug development and anticancer platinum complexes. Her academic journey has been marked by a strong foundation in medicinal chemistry, with a keen interest in exploring the role of isomerism in drug efficacy. During her Ph.D., she conducted extensive research on platinum complexes with glycine derivatives, focusing on their interaction with DNA and anticancer properties. Her work involved molecular docking, dynamic simulations, and in-vitro studies to evaluate the pharmacological potential of these compounds. Through her research, she contributed to the field of coordination chemistry and its applications in medicine. She has actively participated in international conferences, presenting her findings on novel platinum-based therapies. With a passion for drug discovery, Dr. Kadivar continues to apply her expertise in chemistry to enhance the effectiveness of anticancer agents.

🏢Work Experience:

Dr. Diba Kadivar has accumulated over eight years of professional experience as a technical assistant at the Iranian Food and Drug Administration (IFDA). In this role, she has been actively involved in regulatory affairs, pharmaceutical analysis, and drug quality control, ensuring the safety and efficacy of therapeutic compounds. Alongside her administrative responsibilities, she has played a vital role in cancer research, working in laboratory settings to study platinum-based anticancer agents. Her expertise extends to working with cancer and normal cell lines, contributing to drug screening and cytotoxicity assays. Additionally, she has been involved in synthesizing and characterizing novel platinum complexes, focusing on their pharmacological interactions. Dr. Kadivar also collaborates with academic institutions and research centers, aiming to bridge the gap between regulatory science and drug discovery. Her hands-on experience in both research and regulatory affairs makes her a key contributor to pharmaceutical advancements in Iran.

🏅Awards: 

Dr. Diba Kadivar has been recognized for her contributions to inorganic and medicinal chemistry, particularly in the field of platinum-based anticancer research. She has received accolades for her pioneering work on the role of geometric isomerism in anticancer drug efficacy. Her research has been acknowledged at national and international scientific conferences, where she has been invited as a speaker and presenter. She has also played a key role in regulatory initiatives at the Iranian Food and Drug Administration, contributing to drug quality assurance and research-based policy-making. Additionally, her publications in esteemed journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications have received notable citations, highlighting her impact on the field. Dr. Kadivar’s dedication to advancing cancer therapy and pharmaceutical sciences continues to earn her recognition among her peers, further solidifying her reputation as an innovative researcher in medicinal inorganic chemistry.

🔬Research Focus:

Dr. Diba Kadivar’s research primarily revolves around the synthesis, characterization, and biological evaluation of platinum-based anticancer complexes. She investigates the impact of geometric isomerism on drug efficacy, focusing on how structural variations influence DNA interactions and cytotoxicity. Her studies explore novel ligand designs, particularly aliphatic N-substituted glycine derivatives, to enhance the pharmacological properties of platinum complexes. In addition to drug synthesis, she conducts in-vitro studies on cancer and normal cell lines to assess the cytotoxic potential of these compounds. She is also involved in molecular docking and dynamic simulations to predict drug interactions at the molecular level. Furthermore, she has worked on calcium, magnesium, copper, and zinc glycine edible nanocomplexes, aiming to develop biocompatible metal-based therapies. Through her interdisciplinary approach, Dr. Kadivar contributes to bridging chemistry and medicine, paving the way for new, targeted anticancer treatments with improved therapeutic outcomes.

Publication Top Notes:

Pharmacological properties of some 3-substituted indole derivatives, a concise overview

Authors: K. Nikoofar, D. Kadivar, S. Shirzadnia

Citations: 13

Year: 2014

Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer

Authors: D. Kadivar, M. E. Moghadam, B. Notash

Citations: 5

Year: 2024

Novel anticancer agents, Pt complex with 1-pyrrolidineacetic acid ligand: Synthesis, biological activity, DNA interaction, molecular docking, and dynamic study

Authors: D. Kadivar, M. E. Moghadam, M. Rezaeisadat

Year: 2025

 

Assist. Prof. Dr. HamidReza Mirzaei | Mass Spectrometry | Best Researcher Award

Published on by Chemistry Awards

Assist. Prof. Dr. HamidReza Mirzaei | Mass Spectrometry | Best Researcher Award

Assist. Prof. Dr. HamidReza Mirzaei , Nuclear Science and Technology Research Institute (NSTRI) , Iran

Dr. H. R. Mirzaei is an Associate Professor specializing in ion sources and accelerators, currently affiliated with the Nuclear Science and Technology Research Institute (NSTRI) in Tehran, Iran. With a strong academic and research foundation in plasma physics and nuclear engineering, he has been instrumental in advancing the field of electrostatic accelerators and ion source technologies. His expertise extends to plasma simulations and the design of RF and microwave ion sources. Dr. Mirzaei’s contributions include collaboration on the construction of a 150 keV electrostatic accelerator and the development of cutting-edge plasma and ion source systems. He has authored numerous research publications in high-impact journals, focusing on plasma science, simulation, and experimental physics. As a member of the Van de Graaff Laboratory, he remains deeply involved in advancing accelerator technology for various scientific and industrial applications.

Professional Profile

Orcid

Scopus 

Summary of Suitability for Award:

Dr. H. R. Mirzaei’s exceptional achievements, innovative research, and dedication to advancing plasma physics and accelerator technology make him a highly suitable candidate for the “Best Researcher Awards.” His work not only demonstrates scientific rigor but also practical applications, reflecting the award’s emphasis on research excellence and societal impact. Recognizing Dr. Mirzaei would honor his substantial contributions to science and inspire continued innovation in the field.His contributions include the successful construction of a 150 keV electrostatic accelerator, the design of innovative plasma simulation systems, and groundbreaking studies on overdense plasma in ECR ion sources. With a robust academic background in nuclear engineering and electrical engineering, he has published extensively in high-impact journals, advancing the understanding of plasma science and its applications.

🎓Education:

Dr. H. R. Mirzaei pursued his academic journey with a Bachelor of Science in Electrical Engineering from Zanjan University, Iran. Building on his foundational knowledge in engineering, he earned a Master of Science in Nuclear Engineering from Amirkabir University, Tehran. His passion for plasma and accelerator technologies led him to complete a Ph.D. in Nuclear Engineering at the same institution in 2013. Throughout his education, Dr. Mirzaei focused on the intersection of plasma physics and nuclear engineering, honing his expertise in ion sources, electrostatic accelerators, and advanced simulation techniques. His academic achievements laid the groundwork for a successful career in research and development in the field of plasma and accelerator physics.

🏢Work Experience:

Dr. Mirzaei has amassed extensive experience in plasma physics and accelerator technologies. He has been pivotal in the development and construction of a 150 keV electrostatic accelerator and played a significant role in designing and constructing RF and microwave-based ion sources. His expertise has been instrumental in advancing the Van de Graaff Laboratory’s capabilities, where he is an active member. Dr. Mirzaei’s professional endeavors also include leading simulation studies of overdense plasma, optimizing plasma startup methods in tokamaks, and developing resonant plasma sources for space plasma simulation chambers. His collaborative efforts span diverse projects, integrating theoretical, simulation, and practical expertise to innovate in ion source and electrostatic accelerator technologies.

🏅Awards: 

Dr. Mirzaei has received recognition for his outstanding contributions to plasma physics and accelerator research. His efforts in developing the Taban Tokamak and pioneering ion source technologies have earned accolades within the scientific community. He has been invited to present his work at numerous international conferences and has received awards for his contributions to accelerator physics and plasma simulation techniques. Additionally, Dr. Mirzaei’s innovative approaches to plasma source optimization and RF power design have led to notable achievements in the field, further solidifying his reputation as a leading expert in ion source and electrostatic accelerator development.

🔬Research Focus:

Dr. Mirzaei’s research focuses on plasma physics, ion source development, and electrostatic accelerators. His work includes designing advanced RF and microwave plasma sources, optimizing plasma startup techniques for tokamaks, and performing simulation studies of overdense plasma in electron cyclotron resonance (ECR) ion sources. He is particularly interested in the practical applications of ion sources in accelerators, including their use in space plasma simulation chambers and industrial processes. His ongoing projects aim to bridge the gap between theoretical models and experimental implementations, contributing to advancements in accelerator and plasma science.

Publication Top Notes:

Analytical solution versus the Monte Carlo simulation for studying the H+ beam neutralization in H2 gas target neutralizer

Authors: Masoumzadeh, A., Habibi, M., Mirzaei, H.R.

Citations: 0

Year: 2024

Design and simulation of an S-Band tunable solid-state power amplifier as an RF injector into a miniature ECR ion source

Authors: Rahimpour, H., Mirzaei, H., Satri, M.Y., Mobaraki, Z.R.

Citations: 0

Year: 2022

Simulation of ionospheric heating in Iran coordinates with SAMI2 model

Authors: Mirzaei, H., Asadnejad, R., Mahdavi, H., Mohammadiha, A., Kazemi, M.

Citations: 0

Year: 2022

Analysis and design of microwave resonant plasma source for Iranian Space Plasma Simulation Chamber

Authors: Mirzaei, H.R., Kazemi, M., Etaati, G., Kafshgari, M.K., Jelodar, H.R.

Citations: 1

Year: 2022

Analysis and design of a 2.45 GHz RF power source for a miniature electron cyclotron resonance ion source

Authors: Rahimpour, H., Mirzaei, H., Satri, M.Y.

Citations: 1

Year: 2022

The Effect of Removing the High Power Pulse Transformer on the Microwave Pulse Duration in the Preionization Phase in Taban Tokamak

Authors: Rostamifard, D., Amrollahi, R., Iraji, D., Mirzaei, H.

Citations: 0

Year: 2020

Optimizing the Plasma startup through ECR plasma pre-ionization in Taban Tokamak via Triple Langmuir probe

Authors: Mirzaei, H.R., Amrollahi, R., Ghasemi, M.

Citations: 6

Year: 2020

First Results and Plasma Current Start-Up in Taban Tokamak

Authors: Mirzaei, H.R., Amrollahi, R.

Citations: 2

Year: 2019

Observation and investigation of runaway electrons in the start-up phase of Taban Tokamak

Authors: Mirzaei, H., Amrollahi, R., Iraji, D., Rostamifard, D.

Citations: 1

Year: 2019

Alborz tokamak system engineering and design

Authors: Amrollahi, R., Iraji, D., Ghasemi, M., Omrani, M., Souri, S.

Citations: 5

Year: 2019